Literature DB >> 10884552

Characterization of [(3)H]-LY354740 binding to rat mGlu2 and mGlu3 receptors expressed in CHO cells using semliki forest virus vectors.

C Schweitzer1, C Kratzeisen, G Adam, K Lundstrom, P Malherbe, S Ohresser, H Stadler, J Wichmann, T Woltering, V Mutel.   

Abstract

The binding properties of [(3)H]-LY354740 were characterized on rat metabotropic glutamate receptors mGlu2 and mGlu3 expressed in Chinese hamster ovary (CHO) cells using Semliki Forest virus vectors. The saturation isotherm gave K(D) values of 20+/-5 and 53+/-8 nM and B(max) values of 474+/-161 and 667+/-89 fmol/mg protein for mGlu2 and mGlu3 receptors, respectively. NMDA, CaCl(2), DHPG and kainate were inactive up to 1 mM, whereas LY341495, DCG IV and ibotenate inhibited [(3)H]-LY354740 binding with similar potencies on both receptors. L-CCG I, L-AP4, L-AP5, LY354740 and 1S,3R-ACPD were 2- to 4-fold more potent inhibitors of [(3)H]-LY354740 binding to mGlu2 than mGlu3 receptors. However, MPPG and L-AP3 had a 6-fold and DTT a 28-fold preference for mGlu2 over mGlu3. ZnCl(2), at 10 mM, inhibited more than 70% of [(3)H]-LY354740 binding to mGlu2 receptors. At the same concentration it did not affect significantly [(3)H]-LY354740 binding to mGlu3 receptors. On the contrary, glutamate, quisqualate, EGLU and NAAG showed a 3-, 5-, 7- and 12-fold preference for mGlu3 over mGlu2. Finally, GTPgammaS, which partially inhibited the binding on mGlu2 receptors, was inactive to inhibit [(3)H]-LY354740 binding on mGlu3 receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10884552     DOI: 10.1016/s0028-3908(99)00265-8

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  14 in total

Review 1.  Ionotropic and metabotropic glutamate receptor structure and pharmacology.

Authors:  James N C Kew; John A Kemp
Journal:  Psychopharmacology (Berl)       Date:  2005-02-25       Impact factor: 4.530

2.  Selective actions of novel allosteric modulators reveal functional heteromers of metabotropic glutamate receptors in the CNS.

Authors:  Shen Yin; Meredith J Noetzel; Kari A Johnson; Rocio Zamorano; Nidhi Jalan-Sakrikar; Karen J Gregory; P Jeffrey Conn; Colleen M Niswender
Journal:  J Neurosci       Date:  2014-01-01       Impact factor: 6.167

3.  Illuminating the activation mechanisms and allosteric properties of metabotropic glutamate receptors.

Authors:  Etienne Doumazane; Pauline Scholler; Ludovic Fabre; Jurriaan M Zwier; Eric Trinquet; Jean-Philippe Pin; Philippe Rondard
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-04       Impact factor: 11.205

4.  Post-injury administration of NAAG peptidase inhibitor prodrug, PGI-02776, in experimental TBI.

Authors:  Jun-Feng Feng; Ken C Van; Gene G Gurkoff; Christina Kopriva; Rafal T Olszewski; Minsoo Song; Shifeng Sun; Man Xu; Joseph H Neale; Po-Wai Yuen; David A Lowe; Jia Zhou; Bruce G Lyeth
Journal:  Brain Res       Date:  2011-04-20       Impact factor: 3.252

5.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 6.  Progress toward advanced understanding of metabotropic glutamate receptors: structure, signaling and therapeutic indications.

Authors:  Shen Yin; Colleen M Niswender
Journal:  Cell Signal       Date:  2014-05-02       Impact factor: 4.315

7.  N-acetylaspartylglutamate is an agonist at mGluR₃ in vivo and in vitro.

Authors:  Joseph H Neale
Journal:  J Neurochem       Date:  2011-12       Impact factor: 5.372

8.  Prenatal stress induces schizophrenia-like alterations of serotonin 2A and metabotropic glutamate 2 receptors in the adult offspring: role of maternal immune system.

Authors:  Terrell Holloway; José L Moreno; Adrienne Umali; Vinayak Rayannavar; Georgia E Hodes; Scott J Russo; Javier González-Maeso
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

9.  Phencyclidine and dizocilpine induced behaviors reduced by N-acetylaspartylglutamate peptidase inhibition via metabotropic glutamate receptors.

Authors:  Rafal T Olszewski; Marta M Wegorzewska; Ana C Monteiro; Kristyn A Krolikowski; Jia Zhou; Alan P Kozikowski; Katrice Long; John Mastropaolo; Stephen I Deutsch; Joseph H Neale
Journal:  Biol Psychiatry       Date:  2007-06-27       Impact factor: 13.382

10.  NAAG peptidase inhibitor improves motor function and reduces cognitive dysfunction in a model of TBI with secondary hypoxia.

Authors:  Gene G Gurkoff; Jun-Feng Feng; Ken C Van; Ali Izadi; Rahil Ghiasvand; Kiarash Shahlaie; Minsoo Song; David A Lowe; Jia Zhou; Bruce G Lyeth
Journal:  Brain Res       Date:  2013-04-03       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.